{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T15:13:46Z","timestamp":1787498026658,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100025247","name":"North Dakota Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100025247","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.sapharm.2024.04.005","type":"journal-article","created":{"date-parts":[[2024,4,11]],"date-time":"2024-04-11T04:34:27Z","timestamp":1712810067000},"page":"648-653","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Revisiting the opioid and naloxone education (ONE) program: Program evaluation using the RE-AIM model four years later"],"prefix":"10.1016","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6040-1103","authenticated-orcid":false,"given":"Mark A.","family":"Strand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Frenzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.sapharm.2024.04.005_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/pharmacy7030106","article-title":"Community-based pharmacy practice innovation and the role of the community-based pharmacist practitioner in the United States","volume":"7","author":"Goode","year":"2019","journal-title":"Pharmacy"},{"key":"10.1016\/j.sapharm.2024.04.005_bib2","article-title":"Pharmacy contributions to improved population health: expanding the public health roundtable","volume":"17E113","author":"Strand","year":"2020","journal-title":"Prev Chronic Dis"},{"issue":"9","key":"10.1016\/j.sapharm.2024.04.005_bib3","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/j.sapharm.2021.01.001","article-title":"Measuring implementation of medication optimization services: development and validation of an implementation outcomes questionnaire","volume":"17","author":"Livet","year":"2021","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2024.04.005_bib4","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/08897077.2015.1132294","article-title":"Barriers to implementation of opioid overdose prevention programs in Ohio","volume":"37","author":"Winstanley","year":"2016","journal-title":"Subst Abuse"},{"issue":"5","key":"10.1016\/j.sapharm.2024.04.005_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/phar.2114","article-title":"Implementation science to advance care delivery: a primer for pharmacists and other health professionals","volume":"38","author":"Livet","year":"2018","journal-title":"Pharmacotherapy"},{"issue":"3","key":"10.1016\/j.sapharm.2024.04.005_bib6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.sapharm.2015.08.003","article-title":"Model for the evaluation of implementation programs and professional pharmacy services","volume":"12","author":"Moullin","year":"2016","journal-title":"Res Soc Adm Pharm"},{"issue":"8","key":"10.1016\/j.sapharm.2024.04.005_bib7","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.sapharm.2018.10.024","article-title":"Routine opioid outcome monitoring in community pharmacy: pilot implementation study protocol","volume":"15","author":"Nielsen","year":"2019","journal-title":"Res Soc Adm Pharm"},{"issue":"9","key":"10.1016\/j.sapharm.2024.04.005_bib8","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.1016\/j.sapharm.2022.03.019","article-title":"Assessing the comparative effectiveness of implementation strategies for professional services to community pharmacy: a systematic review","volume":"18","author":"Seda","year":"2022","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2024.04.005_bib9","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/1060028019867253","article-title":"The intersection of implementation science and pharmacy practice transformation","volume":"54","author":"Smith","year":"2019","journal-title":"Ann Pharmacother"},{"issue":"1","key":"10.1016\/j.sapharm.2024.04.005_bib10","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1186\/s12913-016-1689-7","article-title":"Qualitative study on the implementation of professional pharmacy services in Australian community pharmacies using framework analysis","volume":"16","author":"Moullin","year":"2016","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.sapharm.2024.04.005_bib11","unstructured":"Center for Disease Control and Prevention [Internet]. The economics of injury and violence prevention. Features, Injury Center. [Cited 2023 June 20] Accessed at https:\/\/www.cdc.gov\/injury\/features\/health-econ-cost-of-injury\/index.html."},{"issue":"1","key":"10.1016\/j.sapharm.2024.04.005_bib12","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1186\/s12913-019-4642-8","article-title":"The effectiveness of prescription drug monitoring programs at reducing opioid-related harms and consequences: a systematic review","volume":"19","author":"Rhodes","year":"2019","journal-title":"BMC Health Serv Res"},{"issue":"7","key":"10.1016\/j.sapharm.2024.04.005_bib13","doi-asserted-by":"crossref","DOI":"10.2105\/AJPH.2023.307329","article-title":"We can't arrest our way out of overdose: the drug bust paradox","volume":"113","author":"Dasgupta","year":"2023","journal-title":"Am J Publ Health"},{"issue":"5","key":"10.1016\/j.sapharm.2024.04.005_bib14","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.sapharm.2017.12.009","article-title":"Promising roles for pharmacists in addressing the U.S. opioid crisis","volume":"1","author":"Compton","year":"2019","journal-title":"Res Soc Adm Pharm"},{"issue":"4","key":"10.1016\/j.sapharm.2024.04.005_bib15","doi-asserted-by":"crossref","DOI":"10.24926\/iip.v11i4.3446","article-title":"Examining attitudes and behaviors that inhibit pharmacist implementation of a statewide opioid harm reduction program","volume":"11","author":"Frenzel","year":"2020","journal-title":"INNOVATIONS Pharm"},{"issue":"2","key":"10.1016\/j.sapharm.2024.04.005_bib16","article-title":"Prevention of prescription opioid misuse and projected overdose deaths in the United States","volume":"2","author":"Chen","year":"2019","journal-title":"J Am Med Assn Network Open"},{"issue":"9","key":"10.1016\/j.sapharm.2024.04.005_bib17","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.sapharm.2019.11.016","article-title":"Program evaluation of the opioid and naloxone education (ONE Rx) program using the RE-AIM model","volume":"16","author":"Strand","year":"2020","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2024.04.005_bib18","doi-asserted-by":"crossref","DOI":"10.5888\/pcd15.180525","article-title":"Dissemination and implementation science for public health professionals: an overview and call to action","volume":"15","author":"Estabrooks","year":"2018","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/j.sapharm.2024.04.005_bib19","doi-asserted-by":"crossref","unstructured":"Estabrooks P. What is RE-AIM? Accessed at http:\/\/www.re-aim.org\/about\/what-is-re-aim\/, July 1, 2019.","DOI":"10.1007\/978-1-4614-6439-6_614-2"},{"key":"10.1016\/j.sapharm.2024.04.005_bib20","unstructured":"ONE Program. Accessed at https:\/\/one-program.org\/, July 21, 2023."},{"issue":"1","key":"10.1016\/j.sapharm.2024.04.005_bib21","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/CEH.0000000000000233","article-title":"Changes in pharmacists' perceptions after a training in opioid misuse and accidental overdose prevention","volume":"39","author":"Eukel","year":"2019","journal-title":"J Continuing Educ Health Prof"},{"issue":"6","key":"10.1016\/j.sapharm.2024.04.005_bib22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/j.1526-4637.2005.00072.x","article-title":"Predicting aberrant behaviors in opioid-treated patients: preliminary validation of the Opioid Risk Tool","volume":"6","author":"Webster","year":"2005","journal-title":"Pain Med"},{"issue":"8","key":"10.1016\/j.sapharm.2024.04.005_bib23","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.sapharm.2018.07.011","article-title":"Moving opioid misuse prevention upstream: a pilot study of community pharmacists screening for opioid misuse risk","volume":"15","author":"Strand","year":"2019","journal-title":"Res Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2024.04.005_bib24","unstructured":"Center for Disease Control and Prevention. U.S. Opioid Dispensing Rate Maps: Drug Overdose, CDC Injury Center. Accessed at https:\/\/www.cdc.gov\/drugoverdose\/rxrate-maps\/index.html, July 11, 2023."},{"key":"10.1016\/j.sapharm.2024.04.005_bib25","first-page":"13127","article-title":"The role of the pharmacist in combating the opioid crisis: an update","author":"Kosobuski","year":"2022","journal-title":"Subst Abuse Rehabil"},{"issue":"1","key":"10.1016\/j.sapharm.2024.04.005_bib26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/87551225221128207","article-title":"A longitudinal comparison of pharmacy documentation platforms using the Technology Acceptance Model: experiences with opioid risk screening","volume":"39","author":"Frenzel","year":"2023","journal-title":"J Pharm Technol"},{"issue":"6","key":"10.1016\/j.sapharm.2024.04.005_bib27","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.sapharm.2015.12.008","article-title":"Prescription drug abuse communication: a qualitative analysis of prescriber and pharmacist perceptions and behaviors","volume":"12","author":"Hagemeier","year":"2016","journal-title":"Res Soc Adm Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2024.04.005_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13012-021-01138-8","article-title":"Data-driven approach for tailoring facilitation strategies to overcome implementation barriers in community pharmacy","volume":"16","author":"Moussa","year":"2021","journal-title":"Implement Sci"},{"issue":"5","key":"10.1016\/j.sapharm.2024.04.005_bib29","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.sapharm.2013.05.003","article-title":"Factors affecting adoption and implementation of AHRQ health literacy tools in pharmacies","volume":"9","author":"Shoemaker","year":"2013","journal-title":"Res Soc Adm Pharm"},{"issue":"10","key":"10.1016\/j.sapharm.2024.04.005_bib30","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/j.sapharm.2021.01.013","article-title":"The influence of intervention complexity on barriers and facilitators in the implementation of professional pharmacy services \u2013 a systematic review","volume":"17","author":"Moecker","year":"2021","journal-title":"Res Soc Adm Pharm"},{"issue":"7","key":"10.1016\/j.sapharm.2024.04.005_bib31","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.2105\/AJPH.2014.301979","article-title":"Using population reach as a proxy metric for intervention impact to prioritize selection of obesity prevention strategies in Los Angeles County, 2010\u20132012","volume":"104","author":"Robles","year":"2014","journal-title":"Am J Publ Health"},{"issue":"1","key":"10.1016\/j.sapharm.2024.04.005_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13722-019-0158-0","article-title":"Leveraging the role of community pharmacists in the prevention, surveillance, and treatment of opioid use disorders","volume":"14","author":"Bach","year":"2019","journal-title":"Addiction Sci Clin Pract"},{"issue":"1","key":"10.1016\/j.sapharm.2024.04.005_bib33","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/s12961-016-0146-8","article-title":"Enhancing implementation science by applying best principles of systems science","volume":"14","author":"Northridge","year":"2016","journal-title":"Health Res Pol Syst"},{"issue":"5","key":"10.1016\/j.sapharm.2024.04.005_bib34","article-title":"Strategies to identify patient risks of prescription opioid addiction when initiating opioids for pain: a systematic review","volume":"2","author":"Klimas","year":"2019","journal-title":"J Am Med Assn Network Open"},{"key":"10.1016\/j.sapharm.2024.04.005_bib35","article-title":"Screening tools for detecting problematic opioid use and potential application to community pharmacy practice: a review","volume":"885","author":"Lindley","year":"2019","journal-title":"Integrated Pharm Res Pract"},{"key":"10.1016\/j.sapharm.2024.04.005_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.107570","article-title":"A community pharmacy-led intervention for opioid medication misuse: a small-scale randomized clinical trial","volume":"205","author":"Cochran","year":"2019","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"10.1016\/j.sapharm.2024.04.005_bib37","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.japh.2018.03.005","article-title":"A community pharmacy intervention for opioid medication misuse: a pilot randomized clinical trial","volume":"58","author":"Cochran","year":"2018","journal-title":"J Amer Pharm Assn"},{"issue":"12","key":"10.1016\/j.sapharm.2024.04.005_bib38","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/j.sapharm.2020.04.012","article-title":"The need to prioritize \u201cprioritization\u201d in clinical pharmacy service practice and implementation","volume":"16","author":"Hohmeier","year":"2020","journal-title":"Res Soc Adm Pharm"},{"issue":"5","key":"10.1016\/j.sapharm.2024.04.005_bib39","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/j.sapharm.2017.06.001","article-title":"Application of the consolidated framework for implementation research to community pharmacy: a framework for implementation research on pharmacy services","volume":"13","author":"Shoemaker","year":"2017","journal-title":"Res Soc Adm Pharm"},{"issue":"5","key":"10.1016\/j.sapharm.2024.04.005_bib40","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.sapharm.2017.04.006","article-title":"Using an array of implementation strategies to improve success rates of pharmacist-initiated medication therapy management services in community pharmacies","volume":"13","author":"Stafford","year":"2017","journal-title":"Res Soc Adm Pharm"},{"issue":"4","key":"10.1016\/j.sapharm.2024.04.005_bib41","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/jcop.21698","article-title":"A practical implementation science heuristic for organizational readiness: r = MC2","volume":"43","author":"Scaccia","year":"2015","journal-title":"J Community Psychol"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124001190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741124001190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T15:46:21Z","timestamp":1718466381000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741124001190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":41,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S1551741124001190"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.04.005","relation":{},"ISSN":["1551-7411"],"issn-type":[{"value":"1551-7411","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Revisiting the opioid and naloxone education (ONE) program: Program evaluation using the RE-AIM model four years later","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2024.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}